nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Betamethasone—multiple sclerosis	0.346	0.632	CbGbCtD
Nandrolone phenpropionate—Progesterone—Prednisolone—multiple sclerosis	0.213	0.535	CrCrCtD
Nandrolone phenpropionate—CYP19A1—Dexamethasone—multiple sclerosis	0.201	0.368	CbGbCtD
Nandrolone phenpropionate—Testosterone—Prednisolone—multiple sclerosis	0.185	0.465	CrCrCtD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0024	0.0563	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0024	0.0563	CbGpPWpGaD
Nandrolone phenpropionate—Ethynodiol—PGR—multiple sclerosis	0.00236	0.204	CrCbGaD
Nandrolone phenpropionate—Norelgestromin—PGR—multiple sclerosis	0.00223	0.193	CrCbGaD
Nandrolone phenpropionate—Norgestimate—PGR—multiple sclerosis	0.00201	0.173	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.00184	0.043	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—PGR—multiple sclerosis	0.00174	0.15	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00165	0.0386	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00149	0.0349	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00149	0.0349	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00147	0.0344	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00147	0.0344	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.00145	0.034	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—PGR—multiple sclerosis	0.00123	0.106	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00121	0.0283	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00121	0.0283	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PGR—multiple sclerosis	0.00117	0.0273	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.00115	0.027	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.00107	0.0251	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—PGR—multiple sclerosis	0.000996	0.086	CrCbGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000939	0.022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000922	0.0216	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—VDR—multiple sclerosis	0.000815	0.0191	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000805	0.0189	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000721	0.0169	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000703	0.0165	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000684	0.016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000644	0.0151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000641	0.015	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000641	0.015	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000632	0.0148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000632	0.0148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000605	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—PGR—multiple sclerosis	0.00058	0.0501	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000561	0.0131	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00054	0.0127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000528	0.0124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000519	0.0122	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000519	0.0122	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000445	0.0104	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000433	0.0101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.00038	0.00891	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000373	0.00874	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000358	0.0084	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000335	0.00784	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	0.000294	0.0069	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000284	0.00666	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ALB—multiple sclerosis	0.00028	0.0242	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000271	0.00636	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000268	0.00629	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000256	0.00601	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ZNF746—multiple sclerosis	0.000254	0.00596	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000246	0.00577	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000246	0.00577	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PTBP1—multiple sclerosis	0.000232	0.00545	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000228	0.00535	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	0.000216	0.00507	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000195	0.00458	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	0.000179	0.00419	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	0.000177	0.00415	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	0.000176	0.00414	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HNRNPA1—multiple sclerosis	0.000176	0.00413	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—U2AF2—multiple sclerosis	0.000176	0.00413	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PGR—multiple sclerosis	0.000159	0.00373	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SRM—multiple sclerosis	0.000156	0.00365	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ALB—multiple sclerosis	0.000154	0.0133	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000144	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ZFP36L1—multiple sclerosis	0.000139	0.00326	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000134	0.00315	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—multiple sclerosis	0.000111	0.00261	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	0.00011	0.00257	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	0.00011	0.00257	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PABPC1—multiple sclerosis	0.000108	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000107	0.00252	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000107	0.00251	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000105	0.00246	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPC5—multiple sclerosis	0.0001	0.00235	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	9.75e-05	0.00229	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPL5—multiple sclerosis	9.74e-05	0.00228	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	9.25e-05	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	9.04e-05	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.9e-05	0.00209	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.88e-05	0.00208	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.71e-05	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RRM1—multiple sclerosis	8.3e-05	0.00195	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.29e-05	0.00194	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.87e-05	0.00184	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PGR—multiple sclerosis	7.67e-05	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.44e-05	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.53e-05	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—multiple sclerosis	5.36e-05	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.05e-05	0.00118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BCHE—multiple sclerosis	4.77e-05	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—multiple sclerosis	4.42e-05	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—multiple sclerosis	2.87e-05	0.000672	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—multiple sclerosis	2.46e-05	0.000578	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—multiple sclerosis	2.25e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—multiple sclerosis	2.13e-05	0.000499	CbGpPWpGaD
